Back

Lung ultrasound, inferior vena cava ultrasound, NT-pro-BNP and discharge body weight as predictors of rehospitalization in acute heart failure

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure: new insights and treatments Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Danilo Martins

Faculty of Medicine of Botucatu, UNESP, Botucatu (Brazil)

6 More presentations in this session

Presentation thumbnail
The experience of more than three hundred levosimendan administrations: what we have learned
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Albuminuria and acute heart failure. Prognostic implications and short-term mortality.
Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes in acute heart failure patients stratified by left ventricular ejection fraction
Doctor A. Feuerstein (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The hemodynamic and cardiometabolic effects of butyrate infusion in ischemic cardiogenic shock
Mr L. Christensen (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
Assessment of biomarkers for iron deficiency following acute decompensated heart failure and its outcomes: a retrospective real-world clinical cohort study
Doctor J. Johansson (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure: new insights and treatments

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic assessment of the combination of subclinical congestion parameters in worsening heart failure events and 90-day mortality
thumbnail
Congress Presentation
Differences in cardiac structure and function across NYHA classes at admission with Acute Heart Failure
thumbnail
Congress Presentation
Evaluating the clinical utility of proBNP in patients with heart failure and low ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources